Peraso Inc. Form 8-K Summary
Business Context and Reporting Period
Company: Peraso Inc. (PRSO)
Filing Date: September 11, 2025
Reporting Period: Current Report (Event Date: September 11, 2025)
Event: Entry into a Material Definitive Agreement (Inducement Offer Letter) to facilitate the exercise of existing warrants and the issuance of new warrants.
Key Financial Metrics and Transaction Details
This filing details a capital raise transaction rather than periodic financial results. Key metrics include:
- Expected Gross Proceeds: Approximately $1.1 million from the exercise of Existing Warrants.
- Shares to be Issued: Up to 952,380 shares of Common Stock upon exercise of Existing Warrants.
- Reduced Exercise Price: Existing Warrants exercise price reduced from $1.61 to $1.18 per share.
- New Warrants Issued: 952,380 Series E warrants issued as inducement.
- New Warrant Exercise Price: $1.25 per share.
- Placement Agent Fees: 9% of gross proceeds (cash) plus reimbursement of expenses up to $45,000.
- Placement Agent Warrants: Warrants to purchase 7% of the shares issued to the Holder (approx. 66,667 shares).
- Use of Proceeds: Working capital and general corporate purposes.
Note: The filing does not provide current revenue, profit, cash flow, margins, or total debt figures.
Material Changes and Transaction Structure
The Company entered into an agreement with a holder of Series C warrants (issued November 6, 2024) to induce the exercise of those warrants. Material changes include:
- Price Reduction: The exercise price for the existing warrants was voluntarily reduced to $1.18 per share.
- Beneficial Ownership Limits: Issuance is subject to the Holder not exceeding beneficial ownership limitations; excess shares are held in abeyance.
- Registration Rights: The Company agreed to file a resale registration statement for the New Warrant Shares within 30 days and use commercially reasonable efforts to have it declared effective within 60 days.
- Lock-Up and Leak-Out: The Holder agreed to a leak-out restriction preventing the transfer of more than 20% of cumulative trading volume for 15 days, unless the stock price is $1.50 or higher.
- Market Standstill: The Company agreed not to issue new equity or file other registration statements for 20 days and not to effect Variable Rate Transactions for 120 days.
Outlook, Risks, and Contingencies
- Closing Date: Expected on or about September 12, 2025, subject to customary closing conditions.
- Warrant Terms: New Warrants are exercisable starting six months after issuance with a 5.5-year term. They include cashless exercise provisions if a registration statement is not effective.
- Fundamental Transactions: In the event of a merger or acquisition, holders may receive shares of the successor entity or cash equal to the Black Scholes Value of the unexercised warrants.
- Voluntary Adjustment: The Board retains the right to reduce the exercise price of the New Warrants at any time, subject to Nasdaq rules.
- Risk of Dilution: The transaction involves the issuance of new shares and warrants, which may dilute existing shareholders.
Investor Verification Checklist
- Verify the actual closing of the transaction and receipt of the ~$1.1 million proceeds.
- Confirm the filing and effectiveness of the resale registration statement (Form S-3) for the New Warrant Shares.
- Monitor the stock price relative to the $1.50 threshold which affects the Holder's leak-out restrictions.
- Review the impact of the 9% placement fee and $45,000 expense reimbursement on net proceeds.
- Check for any subsequent filings regarding the 20-day market standstill or 120-day variable rate transaction moratorium.